Winshine Science Co Ltd

The company's capital structure is highly leveraged, with total liabilities of HKD 548.8 million and total equity of HKD -217.7 million, resulting in a negative debt-to-equity ratio of -1.18. The current ratio of 0.45 indicates significant liquidity constraints, as current assets are insufficient to cover current liabilities [doc:HA-latest]. The negative net income of HKD -92.8 million and operating loss of HKD -79.3 million further underscore the company's financial distress [doc:HA-latest]. Profitability metrics are severely underperforming relative to industry norms. The return on equity (ROE) of 42.65% is misleading due to the negative equity base, while the return on assets (ROA) of -28.04% indicates a substantial underperformance in asset utilization. Gross profit of HKD -30.3 million suggests that the company is not covering its cost of goods sold, a critical red flag for a manufacturing or distribution business [doc:HA-latest]. The company's revenue is concentrated in a single business segment, as disclosed in its latest financials, with no material geographic diversification reported. This lack of diversification increases exposure to regional demand fluctuations and supply chain disruptions [doc:HA-latest]. No material revenue by geographic region is disclosed, but the company's operations are likely concentrated in Asia, given its listing and operational base in Hong Kong [doc:HA-latest]. The company's growth trajectory is negative, with a reported revenue of HKD 382.4 million in the latest period. Analyst estimates suggest a significant discrepancy, with a reported revenue of HKD 873.7 million, indicating potential data inconsistencies or non-GAAP reporting practices [doc:]. The negative net income of HKD -92.8 million and operating loss of HKD -79.3 million suggest a lack of operational momentum [doc:HA-latest]. The company faces high liquidity risk, with a current ratio of 0.45 and negative net cash position. The risk assessment flags "Net cash is negative after subtracting total debt," indicating a severe liquidity crunch. The dilution risk is currently low, but the negative equity position and high leverage increase the potential for future dilution through equity issuance or debt restructuring [doc:HA-latest]. No recent events or filings are disclosed that would explain the financial deterioration, but the negative earnings and liquidity position suggest operational or strategic challenges [doc:HA-latest].